AJP - Endocrinology and Metabolism, Vol 261, Issue 4 E425-E429, Copyright © 1991 by American Physiological Society

ARTICLES

In vivo evidence for hepatic autoregulation during FFA-stimulated gluconeogenesis in normal humans

J. N. Clore, P. S. Glickman, J. E. Nestler and W. G. Blackard
Division of Endocrinology and Metabolism, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0111.

To examine the effect of increased gluconeogenesis [by increasing free fatty acids (FFA)] on hepatic glucose output (HGO) and on the first substrate (glucose) cycle, a primed continuous infusion of [2-3H]- and [6-14C]glucose was infused to isotopic steady state in 12 normal male volunteers after an overnight fast. Blood samples for the determination of glucose specific activity were obtained before and after an infusion of saline (n = 6) or 10% Intralipid and heparin (90 mU.kg-1.min-1, n = 6). Plasma FFA (593.3 +/- 74.5 to 971.1 +/- 127.1 mumol/l, P = 0.007) and glycerol (68.0 +/- 5.9 vs. 222.4 +/- 32.0 mumol/l, P = 0.002) increased during the lipid infusion, and beta-hydroxybutyrate levels rose from 0.24 +/- 0.12 to 0.50 +/- 0.17 mmol/l (P = 0.01). No change in plasma glucose, insulin, or glucagon levels was observed during the study, and levels of the gluconeogenic substrates alanine and lactate were also unchanged. Baseline rates of glucose cycling (rate of appearance of [2-3H]glucose minus rate of appearance of [6-14C]glucose) were similar in the two groups [1.44 +/- 0.33 vs. 1.33 +/- 0.44 mumol.kg-1.min-1, not significant (NS)] and did not change during either saline or lipid infusion, respectively. However, Cori cycle activity (the conversion of [6-14C]- to [1-14C]glucose) increased significantly from 0.59 +/- 0.19 to 1.28 +/- 0.19 mumol.kg-1.min-1 (P = 0.002) after FFA and glycerol levels had been increased, in marked contrast to the saline control (0.51 +/- 0.18 to 0.39 +/- 0.18 mumol.kg-1.min-1, NS).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				M. O. Weickert, C. v. Loeffelholz, M. Roden, V. Chandramouli, A. Brehm, P. Nowotny, M. A. Osterhoff, F. Isken, J. Spranger, B. R. Landau, et al. A Thr94Ala mutation in human liver fatty acid-binding protein contributes to reduced hepatic glycogenolysis and blunted elevation of plasma glucose levels in lipid-exposed subjects Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E1078 - E1084. [Abstract] [Full Text] [PDF]

				D. B. Savage, K. F. Petersen, and G. I. Shulman Disordered Lipid Metabolism and the Pathogenesis of Insulin Resistance Physiol Rev, April 1, 2007; 87(2): 507 - 520. [Abstract] [Full Text] [PDF]

				C. Everett-Grueter, D. S. Edgerton, E. P. Donahue, S. Vaughan, C. A. Chu, D. K. Sindelar, and A. D. Cherrington The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E449 - E459. [Abstract] [Full Text] [PDF]

				A. A. M. W. van Kempen, S. N. van der Crabben, M. T. Ackermans, E. Endert, J. H. Kok, and H. P. Sauerwein Stimulation of gluconeogenesis by intravenous lipids in preterm infants: response depends on fatty acid profile Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E723 - E730. [Abstract] [Full Text] [PDF]

				H. van Thien, G. J. Weverling, M. T. Ackermans, N. canh Hung, E. Endert, P. A. Kager, and H. P. Sauerwein FFAs are not involved in regulation of gluconeogenesis and glycogenolysis in adults with uncomplicated P. falciparum malaria Am J Physiol Endocrinol Metab, October 1, 2004; 287(4): E609 - E615. [Abstract] [Full Text] [PDF]

				J. N. Clore, J. S. Stillman, J. Li, S. J. D. O'Keefe, and J. R. Levy Differential effect of saturated and polyunsaturated fatty acids on hepatic glucose metabolism in humans Am J Physiol Endocrinol Metab, August 1, 2004; 287(2): E358 - E365. [Abstract] [Full Text] [PDF]

				S. M. Gustavson, C. A. Chu, M. Nishizawa, B. Farmer, D. Neal, Y. Yang, S. Vaughan, E. P. Donahue, P. Flakoll, and A. D. Cherrington Glucagon's actions are modified by the combination of epinephrine and gluconeogenic precursor infusion Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E534 - E544. [Abstract] [Full Text] [PDF]

				T. K. T. Lam, A. Carpentier, G. F. Lewis, G. van de Werve, I. G. Fantus, and A. Giacca Mechanisms of the free fatty acid-induced increase in hepatic glucose production Am J Physiol Endocrinol Metab, May 1, 2003; 284(5): E863 - E873. [Abstract] [Full Text] [PDF]

				S. M. Gustavson, C. A. Chu, M. Nishizawa, B. Farmer, D. Neal, Y. Yang, E. P. Donahue, P. Flakoll, and A. D. Cherrington Interaction of glucagon and epinephrine in the control of hepatic glucose production in the conscious dog Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E695 - E707. [Abstract] [Full Text] [PDF]

				T. K. T. Lam, G. Van de Werve, and A. Giacca Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E281 - E290. [Abstract] [Full Text] [PDF]

				C. A. Chu, P. Galassetti, K. Igawa, D. K. Sindelar, D. W. Neal, M. Burish, and A. D. Cherrington Interaction of free fatty acids and epinephrine in regulating hepatic glucose production in conscious dogs Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E291 - E301. [Abstract] [Full Text] [PDF]

				P. Singhal, A. Caumo, P. E. Carey, C. Cobelli, and R. Taylor Regulation of endogenous glucose production after a mixed meal in type 2 diabetes Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E275 - E283. [Abstract] [Full Text] [PDF]

				D. Kirpichnikov, S. I. McFarlane, and J. R. Sowers Metformin: An Update Ann Intern Med, July 2, 2002; 137(1): 25 - 33. [Abstract] [Full Text] [PDF]

				P. Shah, A. Vella, A. Basu, R. Basu, A. Adkins, W. F. Schwenk, C. M. Johnson, K. S. Nair, M. D. Jensen, and R. A. Rizza Effects of Free Fatty Acids and Glycerol on Splanchnic Glucose Metabolism and Insulin Extraction in Nondiabetic Humans Diabetes, February 1, 2002; 51(2): 301 - 310. [Abstract] [Full Text] [PDF]

				V. Rigalleau, C. Binnert, K. Minehira, N. Stefanoni, P. Schneiter, E. Henchoz, O. Matzinger, C. Cayeux, E. Jéquier, and L. Tappy In Normal Men, Free Fatty Acids Reduce Peripheral but Not Splanchnic Glucose Uptake Diabetes, April 1, 2001; 50(4): 727 - 732. [Abstract] [Full Text]

				K. F. Petersen, M. Krssak, V. Navarro, V. Chandramouli, R. Hundal, W. C. Schumann, B. R. Landau, and G. I. Shulman Contributions of net hepatic glycogenolysis and gluconeogenesis to glucose production in cirrhosis Am J Physiol Endocrinol Metab, March 1, 1999; 276(3): E529 - E535. [Abstract] [Full Text] [PDF]

				V. Rigalleau, M. Beylot, C. Pachiaudi, C. Guillot, G. Deleris, and H. Gin Mechanisms of glucose intolerance during triglyceride infusion Am J Physiol Endocrinol Metab, October 1, 1998; 275(4): E641 - E648. [Abstract] [Full Text] [PDF]

				M. Shiota, P. A. Jackson, H. Bischoff, M. McCaleb, M. Scott, M. Monohan, D. W. Neal, and A. D. Cherrington Inhibition of glycogenolysis enhances gluconeogenic precursor uptake by the liver of conscious dogs Am J Physiol Endocrinol Metab, November 1, 1997; 273(5): E868 - E879. [Abstract] [Full Text] [PDF]

				C. A. Chu, S. M. Sherck, K. Igawa, D. K. Sindelar, D. W. Neal, M. Emshwiller, and A. D. Cherrington Effects of free fatty acids on hepatic glycogenolysis and gluconeogenesis in conscious dogs Am J Physiol Endocrinol Metab, February 1, 2002; 282(2): E402 - E411. [Abstract] [Full Text] [PDF]